Inhaled insulin (Afrezza; MannKind Corporation) continues to build a case for broader adoption in pediatric diabetes care.

After FDA approval for children 6 and older, ADA data show inhaled insulin's safety and satisfaction benefits, but clinician ...

The approval of a new oral postexposure prophylaxis for COVID-19 marks a significant advancement in the disease's prevention ...

The moisturizer, sunscreen, or shampoo used in daily routines may contain dozens of plastic-associated chemicals linked to ...

Men and urban minority patients with early-onset CRC face elevated CVD death risk, highlighting gaps in survivorship care and ...

Mixed κ agonism and μ antagonism/partial agonism raises mechanistic and abuse-liability questions, with nausea, vomiting, ...

Ajai Chari, MD, unpacks resistance mechanisms, treatment sequencing, and why myeloma’s future may be brighter than anyone ...

The Medicare GLP-1 Bridge's July 1 launch is now the only concrete milestone on the calendar. Whether it becomes the ...

SEER-Medicare data (n=54,344; mean age 77.7 years) showed significant unadjusted Black-White gaps in localized diagnosis, ...

Among those who received a prior authorization denial, 41% said it delayed their medical care, and 28% said their health ...

Objective: To compare the real-world effects of weekly injectable semaglutide (Ozempic) vs dulaglutide (Trulicity) on weight ...

Alexa Simon Meara, MD, MS, discusses breaking down silos between academic and community oncology to improve immunotherapy ...